Proteogenomics allows for simultaneous, multi “-omic” analyses of DNA, RNA (genomics), and proteins (proteomics) in a tissue sample. The information from this set of analyses can identify why a tumor is resistant to treatment and open possibilities for other effective therapies going forward.
You are here
The Progress Report Progress never stops. Stay informed with the latest news on breast cancer research, treatment, and prevention.
Tag:
Biopsy x
On Wednesday, March 18, The New York Times featured a front page story on a study published in this week’s "Journal of the American Medical Association" (JAMA).